How to Launch a Patient Support Program (PSP) in Just 3 Weeks!

For pharma companies, launching a new therapy is only part of the journey. Ensuring patients start and stay on treatment often depends on having the right support in place from day one. Yet building a digital patient support program (PSP) from scratch can take months, delaying impact, limiting reach, and leaving patients without the tools they need.

The MyTherapy platform changes that. Developed over more than a decade and trusted by millions of patients worldwide, it allows pharma to configure, brand, and deploy a compliant, treatment-specific PSP in as little as 3 weeks, so patients get timely, tailored support, and companies can deliver measurable outcomes faster.

Launching quickly is only the beginning. Long-term success depends on delivering personalized education, timely reminders, and behavior-based support that helps patients stay engaged throughout their treatment journey. This is where personalized patient support transforms a rapid launch into sustained adherence, stronger persistence, and measurable program outcomes.

Why Speed Matters in Digital Health  

Digital patient support programs improve adherence, persistence, and patient outcomes, but their impact depends on reaching patients quickly. In fast-moving healthcare markets, every week counts.  

With more than a decade of refinement, the MyTherapy platform has been built to address the everyday needs of people taking regular medications. It already serves over 12 million patients globally, across every major therapeutic area. This proven infrastructure makes it possible to launch tailored PSPs for specific treatments in just 3 weeks.

The MyTherapy Platform: Ready-to-Use Patient Support

MyTherapy is a free app for iOS and Android, available in 30+ languages and shaped by years of patient feedback and clinical testing.

Core features include:

• Medication reminders
• Inventory tracking & refill alerts
• Symptom tracking
• Activity reminders
• Care team integration
• Appointment management
• PDF health reports
• Drug interaction checker (selected markets)
• Integration with online pharmacies (selected markets)

These capabilities handle complex, real-world medication routines and have been shown to improve self-reported adherence using the validated MARS-5 questionnaire.

The greatest value comes from bringing these capabilities together into a personalized patient support experience that adapts to patients throughout their treatment journey. By combining reminders, education, symptom tracking, and ongoing engagement in one connected platform, pharma teams can improve adherence, strengthen persistence, and deliver more meaningful patient support at scale.

Configurable Modules Based on Patient Needs  

Some patients require additional, therapy-specific support. For these cases, smartpatient works with partners to create custom PSP configurations within MyTherapy, accessible only to the defined patient group.

Modules can include:

• Automated regimen & titration scheduling

• Gamification and Badges

• Onboarding support

• Connectivity to other patient support channels

• Development and integration of SaMD modules according to ISO13485 standards
• Injection site tracking

• Custom educational content

Modules can be configured per market, and new features can be developed in parallel to launch for later updates, avoiding delays.

Every therapy presents unique adherence challenges. Configurable patient support enables pharma teams to tailor onboarding, education, reminders, and behavioral interventions to different treatment journeys while maintaining consistency across brands, markets, and patient populations.

The 3-Week PSP Journey to Launch  

Week 1: Gathering requirements & setting up the program

Define therapy needs, select core features, and identify any configurable modules to ensure the PSP is tailored and compliant.

Configure the PSP on the MyTherapy platform, including branding and a custom setup assistant, plus any therapy-specific modules like titration or injection site tracking.

Week 2: Final alignment and approvals

Run tests and secure medical, legal, and regulatory approvals so the program is fully ready for patients.

Week 3: Acceptance testing and launch

Validate performance with user testing, then roll out the PSP to patients, live in just 3 weeks.

Launching a patient support program is only the first milestone. The greatest long-term value comes from continuously supporting patients with personalized education, timely interventions, and ongoing engagement that improve adherence, persistence, and patient confidence throughout treatment.

See how Personalized Patient Support helps pharmaceutical teams deliver measurable patient engagement beyond launch.

→ Talk to a Patient Support Expert

From MVP to Continuous Growth

Our approach is to launch a Minimum Viable Product, a fully functional, compliant PSP that can evolve based on real-world patient feedback.

Post-launch, we focus on:
• Onboarding existing MyTherapy users
• Running targeted adoption campaigns and HCP outreach
• Reviewing program performance with a Partner Success Manager
• Scaling to new markets or adding advanced functionality over time

The most successful patient support programs continue creating value long after implementation. By combining rapid deployment with personalized education, behavior-based support, and continuous optimization, pharmaceutical organizations can improve patient engagement, strengthen adherence, and deliver measurable long-term outcomes across the treatment journey.

Explore how Personalized Patient Support helps transform digital patient support programs into scalable, measurable engagement strategies.

→ Book a free consultation with one of our Patient Support experts